Trailing-twelve-month (TTM) revenue is $258.85 Million with a year-over-year growth of (14.11%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $70,218,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $61,589,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-09 |
| Q1 FY2026Period ended 2026-03-28 | $58,206,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-27 | $68,832,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $258,845,000 |
Current P/S: $137,252,755 market capitalization ÷ $258,845,000 TTM revenue = 0.53x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-27): $68.83M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:45:55.976Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Fresh | $307M | N/A | N/A |
| Frozen | $18M | N/A | N/A |
| Reporting Segment | N/A | $326M | $275M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $82M | $145M | $115M | $137M | $128M | $112M |
$258.85M
$258.85 Million
(14.11%)
vs. $301.37M a year ago (TTM)
(8.75%)
5 Year compound annual growth rate
1 Year
(14.11%)
3 Year
(12.69%)
5 Year
(8.75%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $275.50M | ($50.96M) | (15.61%) |
| 2024 | $326.45M | ($16.92M) | (4.93%) |
| 2023 | $343.38M | ($75.56M) | (18.04%) |
| 2022 | $418.93M | ($45.77M) | (9.85%) |
| 2021 | $464.70M | +$57.91M | +14.24% |
| 2020 |
TTM Growth
(14.11%)
3-Year CAGR
(12.69%)
5-Year CAGR
(8.75%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 32 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:45:55.976Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $406.79M |
| +$108.89M |
| +36.55% |
| 2019 | $297.90M | +$209.96M | +238.77% |
| 2018 | $87.93M | +$55.35M | +169.89% |
| 2017 | $32.58M | +$16.40M | +101.34% |
